FDA Includes Myocarditis and Pericarditis Warning for Janssen COVID Vaccine
The revision states that the vaccine can cause thrombosis with thrombocytopenia syndrome, which may be life-threatening.
The revision states that the vaccine can cause thrombosis with thrombocytopenia syndrome, which may be life-threatening.
The association joins other medical organizations in emphasizing the hazards of over-the-counter availability of inhaled epinephrine products for the treatment of asthma.
The European Commission expanded the approval of Novavax's COVID-19 vaccine as a booster for adults aged 18 and older.
The experimental ALS drug NU-9 is more effective at treating amyotrophic lateral sclerosis than existing FDA-approved drugs for the disease, according to research from Northwestern University scientists published in Scientific Reports.
Read MorePatients with severe COVID-19 who were treated with imatinib had lower mortality rates at 90-day follow-up, according to research presented at ATS 2022.
Read MoreAmong in ANCA-associated vasculitis patients, Avacopan was better than Prednisone in reducing respiratory and ear, nose and throat (ENT) involvement, while reducing glucocorticoid use.
Read MoreA majority of African American patients with symptomatic sarcoidosis treated with Acthar Gel saw clinical improvement in a number of health factors, including lung function and quality of life, according to data presented at ATS 2022.
Read MoreA greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to tezepelumab (Tezspire) than placebo, according to research presented at ATS 2022.
Read MoreChildren age 5-through-11 are now authorized to receive the Pfizer COVID booster at least five months after completion of their primary two-dose series of the Pfizer vaccine.
Read MoreTwo combinations of albuterol and budesonide used as a rescue medication demonstrated a statistically significant reduction in the risk of a severe exacerbation in patients with moderate to severe asthma.
Read MoreThe FDA approved Olumiant (baricitinib) for hospitalized adults with COVID-19 requiring supplemental oxygen, noninvasive or invasive mechanical ventilation, or ECMO.
Read MoreResearchers at the University of Arizona Health Sciences are using a $6.7 million National Institutes of Health grant to study azithromycin therapy in preschoolers who are diagnosed with severe wheezing episodes at hospital emergency departments.
Read MoreAsthma and allergy drug montelukast (Singulair) can bind to and block a protein produced by the virus SARS-CoV-2 and reduce viral replication.
Read MorePfizer Inc and BioNTech SE have submitted an application for US FDA authorization of a 10-µg booster dose of its pediatric COVID booster for children age 5 through 11 years old.
Read MoreThe US FDA expanded the approval of remdesivir (Veklury, Gilead Sciences) to include pediatric patients 28 days of age and older weighing at least 3 kg with positive results of direct SARS-CoV-2 viral testing.
Read More